ESC 365 - Doctor Carlo Fumagalli

Speaker illustration

Doctor Carlo Fumagalli

Careggi University Hospital (AOUC), Florence (Italy)

Member of:

Frailty and associated outcomes in patients with transthyretin cardiac amyloidosis

Event: ESC Congress 2024

Topic: Infiltrative Myocardial Disease

Session: The different faces of cardiac amyloidosis

Incidence and factors associated with de novo atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: Amyloidosis and aortic stenosis

Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring

Event: ESC Congress 2022

Topic: Hypertrophic Cardiomyopathy

Session: The genetic spectrum of hypertrophic cardiomyopathy

Clinical phenotype and long-term outcome of patients with Anderson-Fabry disease followed at a multidisciplinary cardiomyopathy centre

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: Rare cardiomyopathies

Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy

Event: ESC Congress 2021 - The Digital Experience

Topic: Hypertrophic Cardiomyopathy

Session: Frontiers in prognostic research in hypertrophic cardiomyopathy

Impact of frailty status on medium-term follow up in patients undergoing percutaneous transcatheter aortic valve implantation in a high-flow referral center with high procedural volumes

Event: ESC Congress 2021 - The Digital Experience

Topic: Intervention

Session: Valvular heart disease and infective endocarditis e-posters

Prevalence of device-detected atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy

Event: ESC Congress 2020

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial Disease ePosters

Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7 - related hypertrophic cardiomyopathy.

Event: ESC Congress 2019

Topic: Hypertrophic Cardiomyopathy

Session: Clinical, imaging and genetic advances in hypertrophic cardiomyopathy

Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy

Event: ESC Congress 2018

Topic: Treatment

Session: Treatment aspects of hypertrophic cardiomyopathy

Prevalence of cardiac amyloidosis by age-class in patients presenting with hypertrophic cardiomyopathy

Event: ESC Congress 2018

Topic: Infiltrative Myocardial Disease

Session: Hypertrophic cardiomyopathy

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources